# OnCo record survive-heroes (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/survive-heroes/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "survive-heroes", "NCT06643585" ;
  schema:name "SURVIVE HERoes"@en ;
  schema:alternateName "SURVIVE-HERoes"@en ;
  schema:description "A trial that gives trastuzumab deruxtecan to people with HER2-positive or HER2-low breast cancer whose blood shows the cancer returning before anything is seen on scans."@en ;
  schema:url <https://onco.cc/trials/survive-heroes/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06643585> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  schema:startDate "2025-04-22" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/radar-mrd/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:trials <https://onco.cc/trials/survive-breast-surveillance/> .